Why is Johnson Pharma falling/rising?

As of 15-Sep, Johnson Pharmacare Ltd is currently priced at 0.78, reflecting an increase of 0.01 or 1.3%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite this recent uptick, it is still trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has remained flat, with a 1.30% increase over the last month, but it has significantly underperformed year-to-date and over the past year, with declines of 31.58% and 33.90%, respectively. Notably, the stock is currently 3.85% away from its 52-week low of Rs 0.75. Additionally, there has been a rise in investor participation, with a 10.55% increase in delivery volume compared to the 5-day average, indicating growing interest despite the overall negative performance.
In the broader market context, Johnson Pharmacare's performance over the past week has been flat, while the benchmark Sensex has increased by 1.24%. Over the last month, Johnson's stock has gained 1.30%, which is slightly below the Sensex's 1.47% increase. The stock's year-to-date and one-year performances are significantly worse than the benchmark, which has gained 4.67% and declined by only 1.33%, respectively. This suggests that while there may be some short-term positive movement in Johnson's stock, it is still struggling to keep pace with the broader market trends.